A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Clinical trial NCT03311724 · COMPLETED

Trial details

NCT number: NCT03311724
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2017-10-19
Primary completion: 2018-04-24
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.